We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$1.19B
Cap. Flow
+$398M
Cap. Flow %
3.01%
Top 10 Hldgs %
25.15%
Holding
2,888
New
90
Increased
233
Reduced
1,480
Closed
57

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$651M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$24.1M
3
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$19.4M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$17.9M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$8.93M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.4M
2
AAPL icon
Apple
AAPL
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$10.9M
4
TWTR
Twitter, Inc.
TWTR
+$9.15M
5
Y
Alleghany Corp
Y
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 19.63%
2 Healthcare 13.34%
3 Financials 12.1%
4 Consumer Discretionary 9.16%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVR icon
2201
Invesco Mortgage Capital
IVR
$805M
$216K ﹤0.01%
16,995
– –
ESPR
2202
DELISTED
Esperion Therapeutics
ESPR
$216K ﹤0.01%
34,686
– –
DOMO icon
2203
Domo
DOMO
$187M
$216K ﹤0.01%
15,153
– –
BZH icon
2204
Beazer Homes USA
BZH
$874M
$216K ﹤0.01%
16,908
– –
SRNE
2205
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$215K ﹤0.01%
242,594
+43,714
+22% +$58K
NKTR icon
2206
Nektar Therapeutics
NKTR
$2.57B
$215K ﹤0.01%
6,336
– –
AMAL icon
2207
Amalgamated Financial
AMAL
$1.53B
$215K ﹤0.01%
9,310
+1,849
+25% +$44.8K
WSBF icon
2208
Waterstone Financial
WSBF
$385M
$213K ﹤0.01%
12,373
– –
ALBO
2209
DELISTED
Albireo Pharma Inc
ALBO
$213K ﹤0.01%
9,864
– –
IDT icon
2210
IDT Corp
IDT
$1.67B
$213K ﹤0.01%
7,548
– –
PSFE icon
2211
Paysafe
PSFE
$405M
$212K ﹤0.01%
15,280
+1
+0% +$16
BKD icon
2212
Brookdale Senior Living
BKD
$3B
$212K ﹤0.01%
77,704
-21,940
-22% -$82K
BTAI icon
2213
BioXcel Therapeutics
BTAI
$34.9M
$212K ﹤0.01%
616
– –
CTEV
2214
Claritev Corp
CTEV
$716M
$212K ﹤0.01%
4,601
-606
-12% -$48.4K
SPWH icon
2215
Sportsman's Warehouse
SPWH
$46.8M
$212K ﹤0.01%
22,488
– –
RMR icon
2216
The RMR Group
RMR
$346M
$211K ﹤0.01%
7,468
– –
RUSHB icon
2217
Rush Enterprises Class B
RUSHB
$9.37B
$211K ﹤0.01%
5,624
– –
LCID icon
2218
Lucid Motors
LCID
$2.54B
$211K ﹤0.01%
3,085
-79
-2% -$8.7K
REPX icon
2219
Riley Exploration Permian
REPX
$786M
$211K ﹤0.01%
7,158
– –
SIGA icon
2220
SIGA Technologies
SIGA
$207M
$210K ﹤0.01%
28,561
– –
BOOM icon
2221
DMC Global
BOOM
$153M
$210K ﹤0.01%
10,812
– –
ARCT icon
2222
Arcturus Therapeutics
ARCT
$223M
$209K ﹤0.01%
12,327
– –
EWTX icon
2223
Edgewise Therapeutics
EWTX
$4.69B
$209K ﹤0.01%
23,355
– –
OSUR icon
2224
OraSure Technologies
OSUR
$277M
$209K ﹤0.01%
43,288
– –
MBIN icon
2225
Merchants Bancorp
MBIN
$2.54B
$209K ﹤0.01%
8,577
-880
-9% -$21.4K
87 88
89
90 91

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

MetLife Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, MetLife Investment Management held 2,888 positions worth $13.2B, up 9.9% from $12B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $398M of net new capital in Q4 2022, opening 90 new positions and adding to 233 existing holdings. Its largest new stake was Atlassian: 8,691 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.4M trimmed.

  • MetLife Investment Management's largest Q4 2022 buy was Atlassian: 8,691 shares worth $1.12M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $651M increase.
  • MetLife Investment Management's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.4M.
  • MetLife Investment Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $9.15M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.2B portfolio in Q4 2022.
  • MetLife Investment Management opened 90 new positions and closed 57 in Q4 2022.
  • MetLife Investment Management's portfolio value rose 9.9% quarter-over-quarter to $13.2B.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.